Targeting nitric oxide for tumor therapy.
Antonio
A
Contestabile
D018528:ATP-Binding Cassette Transporters / Q000235:genetics; D000818:Animals; D001943:Breast Neoplasms / Q000378:metabolism / Q000517:prevention & control; D021441:Carcinoma, Pancreatic Ductal / Q000188:drug therapy / Q000378:metabolism / Q000517:prevention & control; D005260:Female; D005910:Glioma / Q000378:metabolism / Q000628:therapy; D006801:Humans; D000071447:N-Myc Proto-Oncogene Protein; D009369:Neoplasms / Q000378:metabolism / Q000517:prevention & control / Q000628:therapy*; D017599:Neuroectodermal Tumors / Q000378:metabolism / Q000473:pathology; D009569:Nitric Oxide / Q000037:antagonists & inhibitors / Q000378:metabolism* / Q000627:therapeutic use; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors / Q000378:metabolism; D009687:Nuclear Proteins / Q000378:metabolism; D015513:Oncogene Proteins / Q000378:metabolism
D018528:ATP-Binding Cassette Transporters; C459801:MYCN protein, human; D000071447:N-Myc Proto-Oncogene Protein; D009687:Nuclear Proteins; D015513:Oncogene Proteins; D009569:Nitric Oxide; D019001:Nitric Oxide Synthase